A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials

par Shoaf, Susan E., Ouyang, John, Sergeyeva, Olga, Estilo, Alvin, Li, Hui, Leung, Deborah
Publié dans Clin J Am Soc Nephrol (2020)

The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations

par Perrone, Ronald D., Chapman, Arlene B., Oberdhan, Dorothee, Czerwiec, Frank S., Sergeyeva, Olga, Ouyang, John, Shoaf, Susan E.
Publié dans Kidney Int Rep (2020)

A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD

par Perrone, Ronald D., Chapman, Arlene B., Oberdhan, Dorothee, Czerwiec, Frank S., Sergeyeva, Olga, Ouyang, John, Shoaf, Susan E.
Publié dans Kidney Int Rep (2020)

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

par Torres, Vicente E., Devuyst, Olivier, Chapman, Arlene B., Gansevoort, Ron T., Perrone, Ronald D., Ouyang, John, Blais, Jaime D., Czerwiec, Frank S., Sergeyeva, Olga
Publié dans Am J Nephrol (2017)

Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

par Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Perrone, Ronald D., Lee, Jennifer, Hoke, Molly E., Estilo, Alvin, Sergeyeva, Olga
Publié dans Clin J Am Soc Nephrol (2021)